WallStreetZenWallStreetZen

NASDAQ: CRGX
Cargo Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Cargo Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CRGX annual revenue was $0.0, with N/A growth year-over-year.

CRGX revenue history

Current Revenue
$0.0
Current Earnings
-$167.5M
Current Profit Margin
0%

Be the first to know when CRGX announces revenue.

CRGX Revenue History By Year

CRGX Yearly RevenueCRGX RevenueCRGX ChangeCRGX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Cargo Therapeutics Revenue FAQ

What was CRGX's revenue last quarter?

Cargo Therapeutics (NASDAQ: CRGX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Cargo Therapeutics's revenue was $0.00.

What was Cargo Therapeutics's revenue in 2024?

Cargo Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Cargo Therapeutics make in a day?

Based on Cargo Therapeutics annual revenue for the past three years, CRGX makes an average of $0.00 per day.

What was Cargo Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Cargo Therapeutics's revenue has grown null year over year. Cargo Therapeutics's revenue in the past year totaled $0.00.

How much does Cargo Therapeutics make in a year?

Cargo Therapeutics's revenue by year for the past three years is:
  • Cargo Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Cargo Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Cargo Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.